Zymeworks Inc (ZYME)
14.14
-0.14
(-0.98%)
USD |
NASDAQ |
Dec 24, 16:00
Zymeworks Free Cash Flow: -59.09M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc | 8.227B |
| Ligand Pharmaceuticals Inc | 6.968M |
| Cellectar Biosciences Inc | -46.57M |
| Revance Therapeutics Inc | -194.91M |
| CNS Pharmaceuticals Inc | -14.18M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.877M |
| Cash from Investing (Quarterly) | 72.26M |
| Cash from Financing (Quarterly) | -14.98M |
| Free Cash Flow Per Share (Quarterly) | -0.0903 |
| Free Cash Flow to Equity (Quarterly) | -6.879M |
| Free Cash Flow to Firm (Quarterly) | -6.879M |
| Free Cash Flow Yield | -5.58% |